AMGN Related Guidance
-
Amgen, Inc. (AMGN) Tops Q1 EPS by 12c, Sales Light; Sees FY EPS Above Midpoint
-
Amgen (AMGN) Will Update on Long-Term Outlook; Guides FY13 EPS Above Views
-
Amgen, Inc. (AMGN) Tops Q4 EPS by 1c
-
Amgen, Inc. (AMGN) Tops Q3 EPS by 20c; Boosts FY12 Outlook
-
Amgen, Inc. (AMGN) Tops Q2 EPS by 29c
-
Amgen, Inc. (AMGN) Misses Q4 EPS by 1c; Guides FY12 EPS
-
Amgen, Inc. (AMGN) Posts Solid Q3 Results; Boosts Buyback to $10B; Raises FY11 EPS Guidance
-
Amgen (AMGN) Tops Q2 EPS by 9c; Sees FY11 at Upper End of Guidance Range; Declares First-Ever Dividend
-
Amgen (AMGN) Reaffirms 2011 and 2015 Guidance
-
Amgen (AMGN) to Pay Q2 Dividend; Announces Additional $5B Buyback; Guides for FY15
-
Amgen Inc. (AMGN) Tops Q4 EPS by 7c; Guides FY11 EPS, Revs
-
Amgen (AMGN) Posts Q3 Adj-EPS of $1.36, Beats by 9c; Reaffirms Guidance
-
Amgen (AMGN) Q2 Profits Fade But Still Surpasses Estimates, Outlook Maintained
-
Amgen (AMGN) Reports Q2 EPS of $1.38, Beats by 8c; Reaffirms
-
Amgen (AMGN) Q1 Views Beat, But Full Year Results Seen at Low End of Range Due to Health Care Reform
-
Amgen (AMGN) Falls A Little Flat On Q4 Results
-
Amgen (AMGN) Misses Street's Q4 Views; Guides FY10
-
Amgen (AMGN) Shares Sink as CEO Says FY09 EPS Will Be at Low End of Guidance Range
-
Amgen (AMGN) Reports Strong Q2 Results; Guides Higher
-
Amgen (AMGN) Misses Q1 View By 7c; Lowers Guidance
-
Cytokinetics (CYTK) Tops Q4 EPS by 17c, Comments on Outlook for 2009
-
Amgen (AMGN) Reports Q4 EPS of $1.06, Misses by 1c; Guides FY09
-
Amgen (AMGN) Tops Q3 Views; Raises FY08 EPS, Sales Guidance
-
Amgen (AMGN) Tops Q2 View; Raises FY08 Guidance
-
Amgen (AMGN) Reports Q1 EPS of $1.12, Beats By 8c; Reaffirms Forecast
-
Amgen (AMGN) Reports Strong Q4 Earnings; Guides Below the Street
-
Amgen (AMGN) said it will exceed 2007 financial forecast - Bloomberg
-
Amgen (AMGN), Johnson & Johnson (JNJ) anemia drug doses shouldn't be lower, panel says - Bloomberg
-
Amgen (AMGN) Cutting 12%-14% of Staff; Lower Guidance
-
Amgen (AMGN) Tops Q2 EPS by 6c; Reaffirms FY EPS forecast
-
Amgen (AMGN) Sees 2007 Adjusted EPS At $4.30 - DJ
-
Amgen (AMGN) sees FY adjusted EPS at the low end of $4.30-$4.50 range
-
Amgen (AMGN) Misses Q4 EPS by 2c, Guides for FY07
-
Amgen (AMGN) Tops Q3 EPS by 6c, Raises Guidance for FY06 Financials
-
Amgen (AMGN) Tops Q2 EPS by 11c; Ups Guidance
-
Amgen (Nasdaq: AMGN) Tops Q1 EPS by 3c, Revenues Light, Guides For Full-Year
-
AMGN Misses Q4 EPS by 1c; Guides
-
AMGN Beat Q2 EPS by 16 Cents; Guides Up
Back to AMGN Stock Lookup
